Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation
Authors
Keywords
Ovarian cancer, MicroRNA, Biomarker
Journal
Cancer Cell International
Volume 13, Issue 1, Pages 86
Publisher
Springer Nature
Online
2013-08-27
DOI
10.1186/1475-2867-13-86
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
- (2013) Srinivas Kondalsamy-Chennakesavan et al. GYNECOLOGIC ONCOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues
- (2012) Peng Guan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation
- (2011) Yanlei Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
- (2011) Sergio Marchini et al. LANCET ONCOLOGY
- Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2
- (2011) A Chao et al. ONCOGENE
- Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours
- (2010) Tae Heon Kim et al. HISTOPATHOLOGY
- A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
- (2010) Ankur K. Nagaraja et al. MOLECULAR ENDOCRINOLOGY
- mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
- (2009) S. Mabuchi et al. CLINICAL CANCER RESEARCH
- Small RNAs Are Raising Big Expectations
- (2009) Karyn Hede JNCI-Journal of the National Cancer Institute
- Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries
- (2009) Stacia K. Wyman et al. PLoS One
- Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers
- (2008) S. K. Chan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- MicroRNA in Cancer Prognosis
- (2008) Frank J. Slack et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
- (2008) Neetu Dahiya et al. PLoS One
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation